SCHEMBL19334352

SCHEMBL19334352

CCc1ccc(NS(=O)(=O)c2ccc(Cl)s2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.67
MAPT P10636 3/20 0.63
PTPN2 P17706 4/20 0.59
PTPN1 P18031 4/20 0.59
PTPN5 P54829 4/20 0.59
SMN1; SMN2 Q16637 4/20 0.57
KMT2A Q03164 5/20 0.54
MEN1 O00255 4/20 0.54
PABPC1 P11940 1/20 0.54
UCHL1 P09936 1/20 0.53
ALDH1A1 P00352 4/20 0.52
HTT P42858 3/20 0.50
NPC1 O15118 2/20 0.50
HPGD P15428 2/20 0.50
TSHR P16473 1/20 0.50
CCR4 P51679 1/20 0.50
KDM4E B2RXH2 1/20 0.50
GAA P10253 1/20 0.50
ALOX12 P18054 1/20 0.50
CASP3 P42574 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5231184 0.82 MAPT (0.68) LMNAMAPTPTPN2PTPN1PTPN5
SCHEMBL7573917 0.80 MAPT (0.64) LMNAMAPTPTPN2PTPN1PTPN5
SCHEMBL29118849 0.80 MAPT (0.64) LMNAMAPTPTPN2PTPN1PTPN5
SCHEMBL7569591 0.80 MAPT (0.68) LMNAMAPTPTPN2PTPN1PTPN5
SCHEMBL7573063 0.79 MAPT (0.63) LMNAMAPTPTPN2PTPN1PTPN5
SCHEMBL29031239 0.77 MAPT (0.58) LMNAMAPTPTPN2PTPN1PTPN5
SCHEMBL7578134 0.77 LMNA (0.71) LMNAMAPTPTPN2PTPN1PTPN5
SCHEMBL5229467 0.76 MEN1 (0.60) LMNAMAPTPTPN2PTPN1PTPN5
SCHEMBL5226104 0.75 SMN1; SMN2 (0.63) LMNAMAPTPTPN2PTPN1PTPN5
SCHEMBL7573143 0.75 ALDH1A1 (0.64) LMNAMAPTPTPN2PTPN1PTPN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9757375-B2 Compounds that inhibit human DNA ligases and methods of treating cancer UNIVERSITY OF MARYLAND, BALTIMORE (US) 2017-09-12 US disclosed